Medulloblastoma (MB), grouped as either WNT-activated, Sonic hedgehog (SHH)-activated, or non-WNT/non-SHH group 3, accounts for almost 20% of all childhood brain cancers. In spite of current intensive treatments, not all patients are cured and survivors suffer from severe side-effects. The present study therefore examined the effects of the poly-ADP-ribose polymerase (PARP) and WEE1-like protein kinase (WEE1) inhibitors, BMN673 and MK-1775, respectively, alone or in combination on four MB cell lines. More specifically, the MB cell lines, DAOY, UW228-3, MED8A and D425, were tested for their sensitivity to BMN673 and MK-1775 alone or in combination, using cell viability, cell confluency and cytotoxicity assays. The effects on the cell cycle phases were also examined using FACS analysis. Monotherapy with BMN673 and MK-1775 exerted dose-dependent inhibitory effects on the viability of almost all MB cell lines. Notably, when BMN673 and MK-1775 were used in combination, synergistic effects were noted in the SHH group cell lines (DAOY and UW228-3), but not in the already WEE1-sensitive group 3 (MED8A and D425) lines. Moreover, the combination treatment decreased the percentage of cells in the G1 phase and induced the novel distribution of both DAOY and UW228-3 cells in the S and G2/M phases, with the UW228-3 cells exhibiting a greater delay. To conclude, MK-1775 was efficient in all and BMN673 in most cell lines, and their combined use exerted synergistic effects on the SHH, but not the group 3 cell lines. These data suggest that MK-1775 alone may be of interest for all MB cell lines, and that the combination of PARP/WEE1 inhibitors may provide possible therapeutic opportunities for the therapy of SHH MBs. Their use warrants further investigations in the future.
This paper provides an overview of recent credit rating-related initiatives in the US and EU, including those at the level of some of the world's leading central banks, together with an assessment of the remaining challenges. The authors argue that (i) notwithstanding concerns over the objectivity and reliability of their ratings, credit rating agencies have, by and large, offered reasonably good estimates of credit quality, (ii) careful consideration is necessary before settling with alternatives, as opposed to complements, to their ratings, (iii) greater transparency in issuer financial information, and improvements in the internal assessment capabilities of financial firms are pre-requisites if reliance on credit ratings is to be further reduced. The authors also conclude that, while central banks have done a lot to reduce their reliance on credit ratings, any further decoupling of their collateral frameworks from credit ratings, beyond the field of sovereign issues, will pose a considerable challenge for them.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.